Catherine M Burzik

CIK 1261141 · Interim CEO · last filed 2025-01-30

Catherine M Burzik is an Interim CEO who has filed 49 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for BDX, was dated Jan 30, 2025. Across all open-market trades the lifetime net is −$1.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.3M across reported positions. 19 SEC filings were submitted jointly with BECTON DICKINSON & CO.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$6.28M
Companies
7
Total Filings
49
Lifetime Open-Market Net
-$1.04M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

KCI price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Related Filers
BECTON DICKINSON & CO — 19 joint filings, latest 2025-01-30
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. — 2 joint filings, latest 2011-12-02
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BDX Director 14,264 $212.12 $3.03M $0 9 2025-01-30
OFIX Interim CEO 112,803 $8.03 $905.2K $50.2K 8 2024-04-09
BECTON DICKINSON & CO (BDXB) Delisted Director 13,425 $48.16 $646.5K $0 3 2023-01-26
HAE Director 19,545 $120.26 $2.35M $0 7 2022-08-08
BECTON DICKINSON & CO (BDXA) Delisted Director 10,832 — — $72.5K 4 2020-01-30
Veradigm Inc. (MDRX) Delisted Director 5,139 $6.81 $35.0K $0 1 2011-12-02
KINETIC CONCEPTS INC (KCI) Delisted President and CEO 108,958 — — -$1.16M 13 2011-04-06

Recent Filings

49 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-01-30 BDX Grant (A) +930 $0 EDGAR
2024-09-16 BDX Notice (144) −400 -$94.3K EDGAR
2024-04-09 OFIX Tax (F) −47,486 -$675.7K EDGAR
2024-01-25 BDX Grant (A) +900 $0 EDGAR
2024-01-25 BDX Grant (A) +923 $0 EDGAR
2023-10-17 OFIX Grant (A) +120,676 $0 EDGAR
2023-09-15 BDX Notice (144) −400 -$104.9K EDGAR
2023-06-21 OFIX Grant (A) +3,589 $0 EDGAR
2023-02-09 OFIX Grant (A) +14,354 $0 EDGAR
2023-01-26 BECTON DICKINSON & CO (BDXB) Delisted Grant (A) +848 $0 EDGAR
Showing 1–10 of 49
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.